Differential Phosphorylation, Desensitization, and Internalization of α1A−Adrenoceptors Activated by Norepinephrine and Oxymetazoline
Open Access
- 1 April 2013
- journal article
- research article
- Published by Elsevier in Molecular Pharmacology
- Vol. 83 (4) , 870-881
Abstract
Loss of response on repetitive drug exposure (i.e., tachyphylaxis) is a particular problem for the vasoconstrictor effects of medications containing oxymetazoline (OXY), an α1-adrenoceptor (AR) agonist of the imidazoline class. One cause of tachyphylaxis is receptor desensitization, usually accompanied by phosphorylation and internalization. It is well established that α1A-ARs are less phosphorylated, desensitized, and internalized on exposure to the phenethylamines norepinephrine (NE), epinephrine, or phenylephrine (PE) than are the α1B and α1D subtypes. However, here we show in human embryonic kidney-293 cells that the low-efficacy agonist OXY induces G protein–coupled receptor kinase 2–dependent α1A-AR phosphorylation, followed by rapid desensitization and internalization (∼40% internalization after 5 minutes of stimulation), whereas phosphorylation of α1A-ARs exposed to NE depends to a large extent on protein kinase C activity and is not followed by desensitization, and the receptors undergo delayed internalization (∼35% after 60 minutes of stimulation). Native α1A-ARs from rat tail artery and vas deferens are also desensitized by OXY, but not by NE or PE, indicating that this property of OXY is not limited to recombinant receptors expressed in cell systems. The results of the present study are clearly indicative of agonist-directed α1A-AR regulation. OXY shows functional selectivity relative to NE and PE at α1A-ARs, leading to significant receptor desensitization and internalization, which is important in view of the therapeutic vasoconstrictor effects of this drug and the varied biologic process regulated by α1A-ARs.Keywords
This publication has 49 references indexed in Scilit:
- Identification and Profiling of Novel α1A-Adrenoceptor-CXC Chemokine Receptor 2 HeteromerJournal of Biological Chemistry, 2012
- Noradrenergic modulation of wakefulness/arousalSleep Medicine Reviews, 2012
- Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane ReceptorsAnnual Review of Pharmacology and Toxicology, 2012
- Long-Term α1A-Adrenergic Receptor Stimulation Improves Synaptic Plasticity, Cognitive Function, Mood, and LongevityMolecular Pharmacology, 2011
- Agonist-selective patterns of µ-opioid receptor phosphorylation revealed by phosphosite-specific antibodiesBritish Journal of Pharmacology, 2011
- The Effect of Protein Kinase C and G Protein-Coupled Receptor Kinase Inhibition on Tolerance Induced by μ-Opioid Agonists of Different EfficacyThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Selective engagement of G protein coupled receptor kinases (GRKs) encodes distinct functions of biased ligandsProceedings of the National Academy of Sciences, 2009
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- α1‐Adrenoceptors are required for normal male sexual functionBritish Journal of Pharmacology, 2007
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000